Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
urinary tract infections/diarrhea
Link salvestatakse lõikelauale
Leht 1 alates 531 tulemused
A Study to Determine the Incidence of Urinary Tract Infections in Infants and Children Ages 4 Months to 6 Years With Febrile Diarrhea.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To determine the incidence of urinary tract infections (UTIs) in infants and children (4 months to 6 years of age) with febrile diarrhea, as outpatients.
METHODS
This was a prospective institutional review board-approved study. patients (between 4 months and 6 years of age) were enrolled
Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Antimicrobial sensitivity tests were performed on four-hundred and ninety-seven bacterial isolates from Sudanese patients with diarrhea or urinary tract infections. Shigella dysenteriae type I and enteropathogenic Escherichia coli showed high resistance rates (percentage of isolates showing
[Urinary tract infection in newborn infants with diarrhea and septicemia].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Urinary tract infection in infants and young children with diarrhea.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Resistant urinary tract infection following neonatal diarrhea.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Adherence characteristics to human small intestinal mucosa of Escherichia coli isolated from patients with diarrhea or urinary tract infections.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Formalin-fixed human ileal mucosa and formalin-fixed or untreated (native) human urinary bladder mucosa were used to test the adherence ability of Escherichia coli enterotoxigenic (ETEC) or uropathogenic (UPEC) for humans. When grown on colonization factor antigen (CFA) agar for 3 h at 37 degrees C,
Urinary tract infection caused by Chromobacterium violaceum.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Chromobacterium violaceum, a proteobacterium, is a facultative anaerobe, which is generally present as the normal flora of water and soil in tropical and subtropical regions. The infection due to Chromobacterium violaceum is rare but mostly fatal. It is responsible for causing fatal cases of
Group d salmonella urinary tract infection in an immunocompetent male.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A 62-year-old male with past medical history of benign prostatic hyperplasia presented to the emergency department with complaints of decreased urinary flow, inability to fully empty his bladder, and gross hematuria. Physical examination was unremarkable. Urinalysis revealed large amount of blood
Urinary tract infection is associated with hypokalemia: a case control study
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background: Hypokalemia is a common clinical problem. The association between urinary tract infection (UTI) and hypokalemia is not clear. Hypokalemia is common in patients with UTI in clinical observation. The aim of the study is to
[Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Cefmenoxime (CMX) was intravenously administered to 106 patients with complicated urinary tract infection at a daily dose of 2-4 g for 5 days. An excellent response in overall clinical efficacy was seen in 15 cases (18.3%), a moderate response in 46 cases (56.1%) and poor response in 21 cases
[Clinical evaluation of aztreonam (AZT) in the treatment of complicated urinary tract infections].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Aztreonam (AZT, Azactam) was given to 176 patients with complicated urinary tract infections (UTI), of whom 110 cases satisfied with the "Criteria of UTI Committee for the Evaluation of Drug Efficacy in the UTI (3rd Ed.)", which was modified by adopting the midstream urine data in cases of women.
Timentin versus piperacillin in the therapy of serious urinary tract infections.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In a comparative study, 47 patients received Timentin, a combination of ticarcillin plus clavulanic acid, or piperacillin to treat serious urinary tract infections. Thirty-nine infections in 38 patients were clinically evaluable (21 in the Timentin-treated group and 18 in the piperacillin-treated
Bacteriuria and urinary tract infections in malnourished children.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
We prospectively examined the incidence of bacteriuria in malnourished patients between 6 months and 5 years of age. For each patient, a normally nourished control matched for age, sex, and presence of fever and diarrhea was included. Of 112 patients (65 boys), 55 had moderate and 57 had severe
[Urinary tract infections in the neonatal intensive care unit: clinical analysis of 229 cases].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To study the clinical features, distribution of pathogens, drug susceptibility, and treatment effectiveness in neonates with urinary tract infection (UTI) and admitted to the neonatal intensive care unit (NICU).
METHODS
The clinical data of 229 neonates who developed UTI during their stay
[A study on the clinical efficacy and safety of cefuzonam with long-term administration in chronic complicated urinary tract infections].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A new member of injectable cephem antibiotics, cefuzonam (L-105, CZON) was administered in the treatment of 11 chronic complicated urinary tract infections (CC-UTI) which were considered to be for indications of long-term chemotherapy. The results obtained are summarized as follows. Responses in 6
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
